U.S. Basic Materials Stock News

Tempus AI, Inc. recently announced a multi-year collaboration with Whitehawk Therapeutics to provide access to its real-world, de-identified multimodal database in support of biomarker-driven research for oncology clinical trials targeting unmet patient needs, particularly in lung and gynecological cancers. This partnership highlights Tempus AI’s expanding influence in precision cancer care as its AI-enabled data platform becomes increasingly integrated into critical biopharma research and...

Earlier this week, Bank of America upgraded Knight-Swift Transportation Holdings, pointing to tightening truckload supply and regulatory changes set to benefit the company’s earnings outlook. An interesting aspect of this upgrade is the focus on upcoming tariffs and enhanced driver regulations, which are expected to further limit trucking capacity and could favor larger operators like Knight-Swift. We'll explore how tightening truckload supply conditions highlighted in the latest upgrade...

If you've been tracking Two Harbors Investment lately, you know this stock can feel like a bit of a roller coaster. Maybe you’re wondering whether this recent ride means now is the time to get in, or if you’re better off waiting on the sidelines. Over just the past week, the stock slipped by 0.7%, and over the last month, it’s down 4.1%. Zooming out further, this year has been tough with a drop of nearly 20%, and over the last year, shares are trailing by 15.5%. Looking even further back, the...

California Resources (CRC) just broke ground on Carbon TerraVault I, the state’s first carbon capture and storage project. The project stands out as a strategic move for CRC and is drawing both regulatory and industry interest. See our latest analysis for California Resources. The Carbon TerraVault milestone and CRC’s recent $400 million senior notes offering have not yet sparked a renewed uptrend, as the stock delivered a 1-year total shareholder return of -4.7% and is still down about 9%...

Eli Lilly (NYSE:LLY) just released pivotal Phase 3 results for its oral diabetes and obesity candidate orforglipron, showing significant benefits over existing therapies. In addition, MonarchE trial data highlighted Verzenio’s long-term survival advantage in high-risk early breast cancer. See our latest analysis for Eli Lilly. Eli Lilly’s year has been marked by a flurry of breakthroughs, from regulatory wins and high-profile hires to substantial global manufacturing investments. The stock’s...

BTIG just initiated coverage on BJ's Wholesale Club Holdings (BJ), highlighting the company's defensive business model and growth outlook. Their recent quarterly results topped expectations, which has helped fuel some renewed optimism among investors. See our latest analysis for BJ's Wholesale Club Holdings. Following BTIG’s upbeat coverage and another strong quarter, BJ’s Wholesale Club Holdings has seen a healthy build in momentum. The stock’s recent 7-day share price return of 4.56% hints...

On October 16, 2025, Danaos Corporation closed a US$500 million offering of 6.875% senior notes due 2032, with proceeds earmarked to redeem its higher-cost 2028 notes and repay secured credit facilities, as well as cover refinancing costs and general corporate purposes. This refinancing marks a significant shift in Danaos' debt structure, reducing interest expense and extending maturity, potentially enhancing financial flexibility and balance sheet resilience. We'll explore how this...

EchoStar (SATS) shares have seen some movement lately, with investors keeping a close watch on the company’s performance this month. Many are weighing how recent trends in the business could shape the stock’s outlook as the year unfolds. See our latest analysis for EchoStar. EchoStar’s share price has skyrocketed lately, surging over 150% in the past three months and delivering a remarkable 218% year-to-date price return. While short-term moves can be brisk, the longer-term total shareholder...

Thermo Fisher Scientific (TMO) shares have edged higher in recent sessions, building on a steady climb that has seen the stock advance roughly 14% over the past month. Investors are reviewing these moves in the context of the company’s current growth outlook. See our latest analysis for Thermo Fisher Scientific. TMO’s recent momentum has shifted perceptions, as the 14% gain in the past month comes after a long stretch where 1-year total shareholder return was negative at -10.1%. While this...

Concentrix (CNXC) is in the spotlight after recent analysis suggested its earnings per share growth has not kept pace with revenue. Management’s latest investments may have negatively affected value for shareholders. See our latest analysis for Concentrix. Concentrix shares have drifted notably lower in recent months, with a sharp 19.2% decline in the past month and a 23.1% drop over the last quarter. This suggests momentum has cooled as investors digested lackluster earnings growth and...

Earlier this week, regional banks such as Ameris Bancorp saw increased investor interest after large US banks reported third-quarter earnings that exceeded Wall Street expectations, supported by a rebound in investment banking and strong trading activity. Atmosphere across financial markets was further buoyed by Federal Reserve Chair Jerome Powell's comments about a potential end to quantitative tightening, a shift that could boost market liquidity and support the banking sector. We'll...

CrowdStrike has been recognized as a Visionary in the 2025 Gartner Magic Quadrant for Security Information and Event Management, highlighting its Falcon Next-Gen SIEM platform advancements with AI-powered detections and real-time streaming technology. This recognition signals growing industry momentum towards replacing legacy SIEM systems with CrowdStrike’s cloud-native, AI-enhanced solutions, reflecting the company’s increasing influence in enterprise cybersecurity modernization. We'll...

Teva Pharmaceutical Industries (NYSE:TEVA) stock has recently drawn investor attention, with performance moving up 5% over the past month and gaining 20% during the past 3 months. This momentum has sparked fresh discussions around the company’s outlook and valuation. See our latest analysis for Teva Pharmaceutical Industries. Zooming out to the bigger picture, Teva’s share price has staged an impressive comeback lately, even as long-term total shareholder returns reveal just how much momentum...

WaFd (WAFD) posted a net profit margin of 29.4%, up from 26.2% a year ago, as EPS climbed with a 21.5% gain over the past year, far outpacing its 5-year average annual earnings growth of 4.3%. The company's Price-to-Earnings ratio is 10.3x, coming in lower than both its peer group average of 12.1x and the broader US banks industry average of 11.6x. Shares currently trade at $28.07, which remains significantly below the estimated fair value of $52.29. With a value-conscious price, an...

PBF Energy (PBF) plans to fully restart its Martinez refinery by the end of 2025, following major demolition and repairs. The company is also reporting progress on cost-saving efforts and renewable diesel production expansion. See our latest analysis for PBF Energy. PBF Energy shares have seen some volatility, with a 17.9% gain over the past 90 days but a 1-year total shareholder return of -10.7%. While the recent refinery news has caught some attention, momentum appears to be building again...

In October 2025, F5 disclosed a sophisticated cybersecurity breach in which nation-state hackers gained persistent access to its networks and stole files from the BIG-IP product suite, prompting emergency warnings from US and UK cybersecurity authorities. An interesting aspect of this event is that the breach involved both the theft of source code and undisclosed security vulnerabilities, affecting a product widely used by Fortune 500 clients and government agencies. We'll examine how this...

Earlier this month, AppLovin shut down its Array app distribution tool following allegations and regulatory concerns that the software enabled some apps to be downloaded on user devices without consent, prompting investigations and scrutiny from authorities including the SEC. Despite the controversy, analysts and investors have focused on AppLovin’s core advertising technology and AI-driven Axon platform, viewing the removal of Array as alleviating risk and highlighting the company's future...

10x Genomics (TXG) announced a partnership with SPT Labtech focused on automating single-cell research workflows. By integrating SPT’s liquid handling system, the collaboration aims to increase scalability and efficiency for researchers. See our latest analysis for 10x Genomics. 10x Genomics’ collaboration with SPT Labtech arrives as the company’s stock continues to face pressure, with a year-to-date share price return of -16.63% and a tough one-year total shareholder return of -23.38%...

Thinking about what to do with DNOW? You are definitely not alone, especially after seeing how this stock has caught both setbacks and surges recently. Zooming out, DNOW has stacked up an impressive 13.3% gain over the past year, and if you’ve been holding longer, you’re probably smiling at that incredible 175.5% growth over five years. On the flip side, the last month was a bit rough, with the stock dipping 7.4%. Last week showed a modest 0.9% pop. It’s been a rollercoaster, and for good...

If you have been watching Wells Fargo lately, you are not alone. With the stock closing at $83.28 and rallying by 7.3% in the last week, many investors are wondering if now is the right time to buy, hold, or consider taking some gains off the table. The one-month gain of 1.0% may look modest, but zoom out and you will see that shares have climbed 18.6% since the start of the year and soared a remarkable 32.3% over the past twelve months. For anyone with a longer-term perspective, that...

Landstar System recently announced it will release its third quarter 2025 results after the market closes on October 28, 2025, with a conference call for analysts and investors scheduled that afternoon. This event comes amid heightened attention on the transportation sector, as strong performance from industry peers has recently impacted investor sentiment toward Landstar. With the transportation sector receiving a boost from robust peer earnings reports, we’ll analyze how this positive...

Recent discussion about expanding the Sphere arena concept to several smaller venues across the U.S. has caught the attention of investors watching Madison Square Garden Entertainment (MSGE), given the possible upside from such growth initiatives. See our latest analysis for Madison Square Garden Entertainment. The excitement over potential new Sphere venues has come as Madison Square Garden Entertainment’s share price gained 23% year-to-date, reflecting renewed optimism around growth...

Regional bank stocks came under pressure after major lenders disclosed deteriorating loan quality and significant charge-offs. This sparked fresh worries about loan losses and profitability. United Bankshares (UBSI) shares moved in line with these broader industry concerns. See our latest analysis for United Bankshares. United Bankshares reflected the sector’s cautious mood, with its share price at $35.23 after a recent string of industry-wide headlines about mounting commercial loan losses...

In the past week, Easterly Government Properties received mixed analyst actions, with Jefferies downgrading the company to "Hold" and Compass Point upgrading it to "Buy." This contrasting analyst sentiment highlights ongoing debates about future growth prospects as the company manages both stable federal leases and rising capital costs. We'll explore how these diverging analyst opinions may influence Easterly's long-term growth outlook and risk profile. AI is about to change healthcare...